FindTrial
Sign In

A comparative study on the effects of dexmedetomidine on the inhalation of sevoflurane for BlockBuster laryngeal mask insertion in obese patients

A comparative study on the effects of dexmedetomidine on the inhalation of sevoflurane for BlockBuster laryngeal mask insertion in obese patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016868
Enrollment
Unknown
Registered
2018-06-30
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Group 1:Sevflurane
Group 2:Sevflurane and dexmetomidine

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. To be selected for general anesthesia with elective surgery; 2. BMI> 35; 3. Aged 18-55 years; 4. ASA Grade I-III; 5. Be able to understand Informed Consent and agree to sign informed consent prior to this study.

Exclusion criteria

Exclusion criteria: 1. uncontrolled high blood pressure, myocardial infarction, ischemic cardiomyopathy, bradycardia or taking beta-blockers; 2. cases of mouth <3cm, neck injury or tumor, unstable cervical spine; 3. Airway disorders, such as occupancy, history of upper respiratory tract infection within 2 weeks, or bleeding tendency; 4. allergic to propofol or sevoflurane; 5. risk of high reflux aspiration.

Design outcomes

Primary

MeasureTime frame
Body movement wen LMA insertion;grading of conditions for LMA insertion;—

Countries

China

Contacts

Public ContactWan Lei

Beijing Friendship Hospital, Capital Medical University

wanleimz@sina.com+86 13401067838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026